Construction of high-fidelity CRISPR/ASCPF1 mutant and uses thereof
AssigneeSouthern Medical University
InventorsZhili Rong, Ying Lin, Hongxin Huang, Lin Shan
Life of this patent
Estimating the term…
Loading patent…
AssigneeSouthern Medical University
InventorsZhili Rong, Ying Lin, Hongxin Huang, Lin Shan
Estimating the term…
A high-fidelity AsCpf1 mutant is obtained by performing a mutation on arginine at position 951 and/or 955 of a AsCpf1 protein amino acid sequence and replacing the same with an amino acid free of forming a hydrogen bond with DNA of a target site; and the amino acid sequence thereof is shown in SEQ ID NOS: 1-3. The encoding gene of the AsCpf1 mutant has a nucleotide sequence as shown in SEQ ID NO: 4 and can be used in the construction of a CRISPR/AsCpf1 gene editing system. A CRISPR/AsCpf1 gene editing system includes a gene encoding a AsCpf1 protein, and the AsCpf1 protein is the AsCpf1 mutant mentioned above. The CRISPR/AsCpf1 gene editing system can be used in lowering an off-target effect of gene editing. The novel AsCpf1 mutant not only retains the gene editing efficiency of wild-type AsCpf1, but also has a higher specificity than the wild-type AsCpf1.
An AsCpf1 mutant comprising SEQ ID NO:
A nucleotide sequence encoding an AsCpf1 mutant having SEQ ID NO:
Dependencies are inferred from the claim text.